首页> 美国卫生研究院文献>PLoS Clinical Trials >Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway
【2h】

Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway

机译:丹参酮IIA通过Akt / Skp2 / p27相关途径抑制低氧诱导的肺动脉平滑肌细胞增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We previously showed that tanshinone IIA ameliorated the hypoxia-induced pulmonary hypertension (HPH) partially by attenuating pulmonary artery remodeling. The hypoxia-induced proliferation of pulmonary artery smooth muscle cells (PASMCs) is one of the major causes for pulmonary arterial remodeling, therefore the present study was performed to explore the effects and underlying mechanism of tanshinone IIA on the hypoxia-induced PASMCs proliferation. PASMCs were isolated from male Sprague-Dawley rats and cultured in normoxic (21%) or hypoxic (3%) condition. Cell proliferation was measured with 3 - (4, 5 - dimethylthiazal - 2 - yl) - 2, 5 - diphenyltetrazoliumbromide assay and cell counting. Cell cycle was measured with flow cytometry. The expression of of p27, Skp-2 and the phosphorylation of Akt were measured using western blot and/or RT-PCR respectively. The results showed that tanshinone IIA significantly inhibited the hypoxia-induced PASMCs proliferation in a concentration-dependent manner and arrested the cells in G1/G0-phase. Tanshinone IIA reversed the hypoxia-induced reduction of p27 protein, a cyclin-dependent kinase inhibitor, in PASMCs by slowing down its degradation. Knockdown of p27 with specific siRNA abolished the anti-proliferation of tanshinone IIA. Moreover, tanshinone IIA inhibited the hypoxia-induced increase of S-phase kinase-associated protein 2 (Skp2) and the phosphorylation of Akt, both of which are involved in the degradation of p27 protein. In vivo tanshinone IIA significantly upregulated the hypoxia-induced p27 protein reduction and downregulated the hypoxia-induced Skp2 increase in pulmonary arteries in HPH rats. Therefore, we propose that the inhibition of tanshinone IIA on hypoxia-induce PASMCs proliferation may be due to arresting the cells in G1/G0-phase by slowing down the hypoxia-induced degradation of p27 via Akt/Skp2-associated pathway. The novel information partially explained the anti-remodeling property of tanshinone IIA on pulmonary artery in HPH.
机译:我们先前显示,丹参酮IIA可通过减弱肺动脉重构来部分缓解缺氧性肺动脉高压(HPH)。低氧诱导的肺动脉平滑肌细胞(PASMCs)增殖是肺动脉重塑的主要原因之一,因此本研究旨在探讨丹参酮IIA对低氧诱导的PASMCs增殖的影响及其潜在机制。从雄性Sprague-Dawley大鼠中分离出PASMC,并在常氧(21%)或低氧(3%)条件下培养。用3-(4,5-二甲基噻唑-2-基)-2-,5-二溴四唑溴化物测定和细胞计数来测量细胞增殖。用流式细胞仪测量细胞周期。分别使用蛋白质印迹和/或RT-PCR检测p27,Skp-2的表达和Akt的磷酸化。结果表明,丹参酮IIA以浓度依赖的方式显着抑制了缺氧诱导的PASMCs增殖,并使细胞停滞在G1 / G0期。丹参酮IIA通过减缓低氧诱导的PASMC中p27蛋白(细胞周期蛋白依赖性激酶抑制剂)的逆转,从而降低了其降解速度。用特异性siRNA抑制p27可以消除丹参酮IIA的抗增殖作用。此外,丹参酮IIA抑制了缺氧诱导的S期激酶相关蛋白2(Skp2)的增加和Akt的磷酸化,两者均参与p27蛋白的降解。体内丹参酮IIA显着上调了缺氧诱导的HPH大鼠肺动脉中p27蛋白的减少,并下调了缺氧诱导的Skp2的表达。因此,我们认为丹参酮IIA抑制缺氧可诱导PASMCs增殖,可能是由于通过Akt / Skp2相关途径减慢了缺氧诱导的p27降解而将细胞停滞在G1 / G0期。新信息部分解释了丹参酮IIA对HPH肺动脉的抗重塑特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号